Paclitaxel resistance in untransformed human mammary epithelial cells is associated with an aneuploidy-prone phenotype.
Despite its increasing clinical use, almost no data are currently available about paclitaxel effects on non-cancerous mammary epithelial cells. We have previously established paclitaxel-resistant sub-cell lines (paclitaxel-surviving populations, PSPs; n=20), and sensitive controls (control clones, CCs; n=10), from the untransformed human mammary epithelial cell line HME1. In this study, we aimed to establish whether paclitaxel resistance was associated with a modified sensitivity to paclitaxel-induced aneuploidy. For this purpose, we analysed basal and paclitaxel-induced chromosome missegregation, apoptosis and aberrant spindle multipolarisation as well as microtubular network composition for each subline. PSP sublines showed higher basal and paclitaxel-induced chromosome missegregation than the CC sublines. This phenomenon was associated with resistance to paclitaxel-induced apoptosis. No significant difference in paclitaxel-induced spindle pole abnormalities between CC and PSP sublines was found. Besides, we showed that a majority of PSPs display a constitutively disrupted microtubular network composition due to aberrant tubulin expression and post-translational modifications. These results clearly indicate that paclitaxel resistance in untransformed human mammary epithelial cells is related to an increased susceptibility to acquire aneuploidy in response to this agent. The consequences of these paclitaxel-associated alterations could be deleterious as they can potentially trigger tumorigenesis.
Bouchet
B P
BP
Université de Lyon, Lyon, F-69622, France. bouchetb@lyon.fnclcc.fr
Bertholon
J
J
Falette
N
N
Audoynaud
C
C
Lamblot
C
C
Puisieux
A
A
Galmarini
C M
CM
D000782:Aneuploidy; D000972:Antineoplastic Agents, Phytogenic / Q000494:pharmacology*; D017209:Apoptosis; D015153:Blotting, Western; D020090:Chromosome Segregation; D019008:Drug Resistance, Neoplasm; D004847:Epithelial Cells / Q000187:drug effects / Q000473:pathology; D005260:Female; D006801:Humans; D042361:Mammary Glands, Human / Q000187:drug effects* / Q000473:pathology; D017239:Paclitaxel / Q000494:pharmacology*; D010641:Phenotype
D000972:Antineoplastic Agents, Phytogenic; D017239:Paclitaxel